Australia's largest stock trading and investment forum Australia's #1 stock forum

BAL

0.00%

$13.23 bellamy's australia limited

BAL - Chart, page-3605

First 3605 Last

Share
Profile

Follow
rallyup

1,229 Posts.

140

27/08/19

09:19

Post #: 40165596
Share

Originally posted by LithiumGold: ↑

Remember fom the H1 reoport:-

"Given the further delay in SAMR registration it is now possible to guide to FY19 Group Revenue. Based on the 1H19 result and early 2H19 trading Bellamy’s updates its outlook to: • Group Revenue for FY19 of $275-300m, allowing for slower trading prior to the rebrand and during the lunar new year holiday, with an expected return to stronger performance from March • Normalised Group EBITDA of 18-22% of revenue, reflecting lower forecast revenue and increased investment in marketing and the China team over the coming period The business retains high confidence in the rebrand, our new product pipeline, continued food growth and successful SAMR registration. Although we remain mindful of the inherent risks of our industry and markets, we strongly believe the medium-term outlook remains compelling, supported by category fundamentals, our differentiated position and an aggressive three-year growth strategy."

These numbers are critical in tomorrows report:-

Group Revenue for FY19 of $275-300m,
Group EBITDA of 18-22% of revenue,

I believe BAL have been fairly conservative with these estimates which opens the possibilty of beating these guidance figures which is opposite to A2M where they were set up to not be able to beat unrealistic guidance figures.

Expand

FY20 guidance is key tomorrow not FY19 imo.

BAL Price at posting: $7.89 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 129 more messages in this thread...

First 3605 Last

Add BAL (ASX) to my watchlist

BAL - Chart, page-3605

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KalGold rolls out detailed aeromagnetic survey across Pinjin project

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

ACCC seeks Olam divestments before it can buy Namoi Cotton

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News